In August 2019, alerts issued by the Rapex system for EU consumers led to 10 cosmetic products being withdrawn from the EU market. Would you like to know the reasons for the ban on each of them? !Read more!
Rapex Report 2 August 2019
Rapex Report, August 2019 – In August, the first week was quiet – and not just for the cosmetics sector… Of the 33 product recalls that took place and were reported to the Rapex system, none were related to cosmetics, tattoo inks or personal care products.
Rapex Report 9 August 2019
In the second week of August, 53 products were recalled from the eurozone via the Rapex system. Of these, none were recalled at the request of the Spanish authorities. In the cosmetics sector, one product was recalled hand soap which contained the preservative methylisothiazolinone, which can cause allergic dermatitis and is not permitted under the Regulation for leave-on cosmetic products.
Rapex Report 16 August 2019
Rapex Report, August 2019 – Friday 16th was the busiest day for the cosmetics sector throughout the month of August. Of the 47 products recalled by the Rapex system – all of which were outside our borders – a total of 6 fell into the cosmetics category.
Five of these were seized at the request of the Lithuanian authorities; all of them were body gels and creams containing the following preservatives MCI y MI. In addition, a skin-lightening cream was withdrawn from the market; its ingredients included kojic acid.
Rapex Report 23 August 2019
On Friday 23 August, only 17 product recalls were reported across the eurozone, a very low figure, perhaps attributable to the holiday period during which the report was compiled. However, one of them was a cosmetic product: a body gel manufactured by Horse Health in Russia, which contained the MI and MCI preservatives, which are not permitted in the EU for leave-on cosmetics.
Rapex Report 30 August 2019
In the latest Rapex report for August, national authorities across the EU withdrew 26 products from the market, none of which were withdrawn at Spain’s request.
In the cosmetics sector, the Czech authorities have withdrawn two products from eyelash growth serum for the same reason: to contain biimataprost, an ingredient that must be used under the supervision of an ophthalmologist and therefore does not comply with Regulation 1223/2009 on cosmetic products.
Other news about the Rapex System
Would you like to find out more about the Rapex System’s weekly alerts? Have a look! A new report is published every Friday on its website.
Would you prefer to read other articles by GTF M. Camps, featuring summaries of Rapex alerts, on our blog? Here it is!